Latest Breaking News On - Christina tartaglia - Page 13 : comparemela.com

Disc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers

Disc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

John quiselChristina tartagliaDisc medicine incVerge scientific communicationsMedicine initiatesTransmembrane serine proteaseChief executive officerFast trackMabwell therapeuticsPrivate securities litigation reform actDiamond blackfan anemiaAnnual reportQuarterly reports

Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera

Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesChristina tartagliaJohn quiselDrug administrationVerge scientific communicationsDisc medicine incDisc medicineUnited states foodFast track designationFast trackChief executive officerTransmembrane serine proteaseMabwell therapeuticsPolycythemia veraPrivate securities litigation reform actDiamond blackfan anemia

Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera

Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesChristina tartagliaJohn quiselDisc medicine incDrug administrationVerge scientific communicationsTrack designationUnited states foodFast track designationFast trackChief executive officerTransmembrane serine proteaseMabwell therapeuticsPolycythemia veraPrivate securities litigation reform actDiamond blackfan anemia

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAmy phillipsChristina tartagliaEyepoint pharmaceuticalsEyepoint pharmaceuticals incGreen room communicationsEyepoint pharmaceuticals nasdaqCompensation committeeEyepoint pharmaceuticals reports inducement grants underPoint pharmaceuticalsTerm incentive planEyepoint pharmaceutical

EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023

- Interim analysis of masked data shows EYP-1901 is well tolerated with no reported drug-related ocular or systemic serious adverse events in Phase 2 PAVIA clinical trial in non-proliferative diabetic.

United statesChristina tartagliaAmy phillipsJays dukerGlobenewswire incBetta pharmaceuticalsEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticals incAlimera sciencesEyepoint pharmaceuticalsExchange commissionGreen room communicationsEquinox sciencesPoint pharmaceuticalsChief executive officerPrivate securities litigation reform act